Daniel Reznicek, MD explains the differences between a TURP (transurethral resection of the prostate, also known as a "roto-rooter") and a Urolift procedure. Both are treatments for men’s lower urinary tract symptoms due to benign prostatic hyperplasia, but are very different procedures and have different risks and benefits. The Urolift was FDA approved in 2013 and is a minimally invasive procedure to help open the urethra with the use of very tiny implants in the prostate. Rather than destroy tissue, it compresses the tissues and has a lower side effect profile than the TURP. In 2018, the Urolift was added as an option that should be considered for the treatment of BPH in the American Urological Association Guidelines. Trials have shown good efficacy and a low side effect profile. The treatment is not for everyone, it works well for some anatomies and not for others.

See more at our website:

https://pacificnorthwesturology.com/urolift.html